{"entity":{"type":"insider","cik":"0001522480","url":"/insider/0001522480","json_url":"/insider/0001522480.json","name":"MAULDIN JOHN F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2012-04-26","last":"2014-01-02","span_basis":"filed_date"},"name_variants":[{"name":"MAULDIN JOHN F","source":"filing","n_filings":10,"first_seen":"2012-04-26","last_seen":"2014-01-02"}],"transactions":[{"id":6393054,"accession":"0000914062-14-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-14-000002","line_url":"/filing/0000914062-14-000002#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":618.0,"shares_display":"618","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":4950.18,"total_display":"4,950.18","total_whole":"4,950","shares_owned_after":18074.0,"shares_owned_after_display":"18,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-02","scope":"insider"},{"id":4325868,"accession":"0000914062-13-000365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000365","line_url":"/filing/0000914062-13-000365#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":609.0,"shares_display":"609","price_per_share":8.1967,"price_display":"8.20","price_state":"stated","total_value":4991.7903,"total_display":"4,991.79","total_whole":"4,992","shares_owned_after":17456.0,"shares_owned_after_display":"17,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-03","scope":"insider"},{"id":5521568,"accession":"0000914062-13-000255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000255","line_url":"/filing/0000914062-13-000255#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":478.0,"shares_display":"478","price_per_share":10.4288,"price_display":"10.43","price_state":"stated","total_value":4984.9664,"total_display":"4,984.97","total_whole":"4,985","shares_owned_after":16847.0,"shares_owned_after_display":"16,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-04","scope":"insider"},{"id":5463465,"accession":"0000914062-13-000232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914062-13-000232","line_url":"/filing/0000914062-13-000232#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125.0,"shares_display":"125","price_per_share":9.97,"price_display":"9.97","price_state":"stated","total_value":1246.25,"total_display":"1,246.25","total_whole":"1,246","shares_owned_after":16369.0,"shares_owned_after_display":"16,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-02","filed_date":"2013-10-03","scope":"insider"},{"id":5463461,"accession":"0000914062-13-000232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000232","line_url":"/filing/0000914062-13-000232#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":376.0,"shares_display":"376","price_per_share":9.9634,"price_display":"9.96","price_state":"stated","total_value":3746.2384,"total_display":"3,746.24","total_whole":"3,746","shares_owned_after":16244.0,"shares_owned_after_display":"16,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider"},{"id":4325856,"accession":"0000914062-13-000230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000230","line_url":"/filing/0000914062-13-000230#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":676.0,"shares_display":"676","price_per_share":7.3785,"price_display":"7.38","price_state":"stated","total_value":4987.866,"total_display":"4,987.87","total_whole":"4,988","shares_owned_after":15868.0,"shares_owned_after_display":"15,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-04","filed_date":"2013-09-06","scope":"insider"},{"id":4515734,"accession":"0000914062-13-000218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000218","line_url":"/filing/0000914062-13-000218#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":840.0,"shares_display":"840","price_per_share":5.9379,"price_display":"5.94","price_state":"stated","total_value":4987.836,"total_display":"4,987.84","total_whole":"4,988","shares_owned_after":15192.0,"shares_owned_after_display":"15,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-05","filed_date":"2013-08-06","scope":"insider"},{"id":5463457,"accession":"0000914062-13-000211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000211","line_url":"/filing/0000914062-13-000211#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":876.0,"shares_display":"876","price_per_share":4.2337,"price_display":"4.23","price_state":"stated","total_value":3708.7212,"total_display":"3,708.72","total_whole":"3,709","shares_owned_after":14352.0,"shares_owned_after_display":"14,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-03","filed_date":"2013-07-08","scope":"insider"},{"id":4217204,"accession":"0000914062-13-000209","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000209","line_url":"/filing/0000914062-13-000209#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":4.2433,"price_display":"4.24","price_state":"stated","total_value":1272.99,"total_display":"1,272.99","total_whole":"1,273","shares_owned_after":13476.0,"shares_owned_after_display":"13,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-03","scope":"insider"},{"id":5146126,"accession":"0000914062-13-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000197","line_url":"/filing/0000914062-13-000197#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1176.0,"shares_display":"1,176","price_per_share":4.2128,"price_display":"4.21","price_state":"stated","total_value":4954.2528,"total_display":"4,954.25","total_whole":"4,954","shares_owned_after":13176.0,"shares_owned_after_display":"13,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-03","filed_date":"2013-06-04","scope":"insider"},{"id":2497718,"accession":"0001181431-12-025889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-025889","line_url":"/filing/0001181431-12-025889#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":3388.0,"total_display":"3,388.00","total_whole":"3,388","shares_owned_after":4947.0,"shares_owned_after_display":"4,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-25","filed_date":"2012-04-26","scope":"insider"},{"id":2497711,"accession":"0001181431-12-025889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-025889","line_url":"/filing/0001181431-12-025889#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522480","owner_name":"MAULDIN JOHN F","owner_display_name":"MAULDIN JOHN F","owner_url":"/insider/0001522480","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3847.0,"shares_display":"3,847","price_per_share":2.94,"price_display":"2.94","price_state":"stated","total_value":11310.18,"total_display":"11,310.18","total_whole":"11,310","shares_owned_after":3847.0,"shares_owned_after_display":"3,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-24","filed_date":"2012-04-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director","n_filings":10,"first_seen":"2012-04-26","last_seen":"2014-01-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001522480","retrieved_at":"2026-08-23T11:09:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}